<DOC>
	<DOCNO>NCT02831426</DOCNO>
	<brief_summary>The rationale present trial conception design move forward assumption subcutaneous , pre-pectoral reconstruction mean soft tissue replacement device feasible , safe give reward result compare standard retro-pectoral technique . Ahead , trial aim test difference outcomes biological synthetic material place support mastectomy skin flap , term immediate complication long-term result .</brief_summary>
	<brief_title>Pre-pectoral Breast Reconstruction PART 2</brief_title>
	<detailed_description>This phase III randomize clinical trial investigate Two-stage , use Tissue Expander ( TE ) pre-pectoral reconstruction . The trial comprise two arm : PRE-PECTORAL technique biological Acellular Dermal Matrix ( ADM ) prosthesis coverage support + FAT GRAFTING VS PRE-PECTORAL technique synthetic Titanium Coated Polypropylene Mesh ( TCPM ) prosthesis coverage support + FAT GRAFTING</detailed_description>
	<criteria>Inclusion criterion entail case conservative mastectomy ( skinsparing mastectomy SSM , nipplesparing mastectomy NSM skinreducing mastectomy SRM ) , prophylactic therapeutic . Included patient baseline characteristic : age 1880 year old BMI 18.5 35 . Former smoker ( 3 week surgery ) hypertension oral medication diabetes previous breast surgery previous breast chest wall radiation therapy allow . T4 metastatic breast cancer obese patient ( BMI 35 ) currently smoke patient ( within 3 week surgery ) refusal sign consent severe comorbidities require chronic therapy ( renal failure , heart failure , cardiovascular disease , pulmonary disease , hepatic disease , metabolic disease ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>